Improved lung function in patients with moderate asthma severity observed with … – News-Medical.net

Improved lung function in patients with moderate asthma severity observed with …
News-Medical.net
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies …

and more »